Aptexx and KeyBank Partner to Offer Innovative Property

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Aptexx and KeyBank Partner to Offer Innovative Property Management and Rent Payments Solutions

CENTURY CITY, CA--(Marketwired - Dec 1, 2015) - Aptexx, a provider of payment and property management software , today announced that it has entered into a strategic partnership with KeyBank ( NYSE : KEY ).

Aptexx's Resident Anywhere™ service, combined with Key's real estate industry expertise and payments capabilities, provides property owners and managers with a centralized, mobile-first solution to collect rent payments, receive maintenance requests, deliver resident communications and administer one-click micro-surveys. The micro-surveys, which are delivered by text or email, provide property managers with deep insights and improved resident engagement. Property owners also benefit from higher occupancy rates, streamlined cash flow and increased net operating income.

Aptexx's SaaS-based platform is designed to integrate with real estate accounting systems, and allows property managers to bring new properties online without the need for heavy IT resources.

Combining Aptexx's focused approach to helping property managers improve the resident experience with Key's broad range of payments expertise creates one of the most dynamic solutions in the market today.

"Key's reputation as a leading provider of commercial real estate finance and payments capabilities makes it the ideal partner for our company," said Aptexx Founder and CEO William Evick. "We are pleased to have such an innovative bank as a partner. The team has demonstrated a strong commitment to the partnership with a focus on delivering a truly great client experience."

"This partnership with Aptexx exemplifies our strategy to leverage leading-edge fintech innovations and couple them with our deep industry expertise to deliver solutions that address our clients' specific needs," said Group Head of KeyBank Enterprise Commercial Payments Clark Khayat. "A simplified resident experience improves electronic payment adoption, which helps our real estate clients run their businesses better every day."

About Aptexx   Aptexx helps property managers improve their processes by delivering targeted, mobile-first software solutions. They are delivered by a team with decades of experience in property management, payment processing and mobile messaging. Aptexx empowers property managers by reducing resident turnover and increasing the bottom line through integrated mobile rent payments, turn-key resident messaging, mobile maintenance requests, real-time emergency notifications and powerful resident surveying services. http://www.aptexx.com .

About KeyCorp   KeyCorp ( NYSE : KEY ) was organized more than 160 years ago and is headquartered in Cleveland, Ohio. One of the nation's largest bank-based financial services companies, Key had assets of approximately $95.4 billion at September 30, 2015. Key provides deposit, lending, cash management and investment services to individuals and small and mid-sized businesses in 12 states under the name KeyBank National Association. Key also provides a broad range of sophisticated corporate and investment banking products, such as merger and acquisition advice, public and private debt and equity, syndications and derivatives to middle market companies in selected industries throughout the United States under the KeyBanc Capital Markets trade name. For more information, visit https://www.key.com . KeyBank is Member FDIC.

CONTACT: Brad Kostka 216.902.3800 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles